{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:32:27Z","timestamp":1782124347150,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AG056728"],"award-info":[{"award-number":["1R01AG056728"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG055362"],"award-info":[{"award-number":["R01AG055362"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2 TR001862"],"award-info":[{"award-number":["KL2 TR001862"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health","award":["T32AR07107"],"award-info":[{"award-number":["T32AR07107"]}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Quest Diagnostic"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10875-022-01296-4","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:02:27Z","timestamp":1655438547000},"page":"1137-1150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency"],"prefix":"10.1007","volume":"42","author":[{"given":"Junghee Jenny","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennefer","family":"Par-Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhan","family":"Unlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jai","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Sun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renelle J.","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Afinogenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mamula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence Ida","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Racke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bucala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Wilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7483-1171","authenticated-orcid":false,"given":"Insoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"issue":"8","key":"1296_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","volume":"35","author":"C Picard","year":"2015","unstructured":"Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35(8):696\u2013726.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1296_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","volume":"38","author":"C Picard","year":"2018","unstructured":"Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96\u2013128.","journal-title":"J Clin Immunol"},{"issue":"7","key":"1296_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3466","volume":"13","author":"A Durandy","year":"2013","unstructured":"Durandy A, Kracker S, Fischer A. Primary antibody deficiencies. Nat Rev Immunol. 2013;13(7):519\u201333.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1296_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2249.2007.03432.x","volume":"149","author":"P Wood","year":"2007","unstructured":"Wood P, Stanworth S, Burton J, Jones A, Peckham DG, Green T, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149(3):410\u201323.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1296_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","volume":"147","author":"AM Shields","year":"2021","unstructured":"Shields AM, Burns SO, Savic S, Richter AG. COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147(3):870-5.e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"1296_CR6","doi-asserted-by":"publisher","first-page":"e0257641","DOI":"10.1371\/journal.pone.0257641","volume":"16","author":"MS Baek","year":"2021","unstructured":"Baek MS, Lee M-T, Kim W-Y, Choi JC, Jung S-Y. COVID-19-related outcomes in immunocompromised patients: a nationwide study in Korea. PLoS\u00a0One. 2021;16(10):e0257641.","journal-title":"PLoS ONE"},{"key":"1296_CR7","doi-asserted-by":"publisher","first-page":"727850","DOI":"10.3389\/fimmu.2021.727850","volume":"12","author":"D Amodio","year":"2021","unstructured":"Amodio D, Ruggiero A, Sgrulletti M, Pighi C, Cotugno N, Medri C, et al. Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies. Front Immunol. 2021;12:727850.","journal-title":"Front Immunol"},{"issue":"2","key":"1296_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10875-021-01174-5","volume":"42","author":"D Arroyo-Sanchez","year":"2021","unstructured":"Arroyo-Sanchez D, Cabrera-Marante O, Laguna-Goya R, Almendro-Vazquez P, Carretero O, Gil-Etayo FJ, et al. Immunogenicity of anti-SARS-CoV-2 vaccines in common variable immunodeficiency. J Clin Immunol. 2021;42(2):240\u201352.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1296_CR9","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.jaci.2021.08.016","volume":"148","author":"OM Delmonte","year":"2021","unstructured":"Delmonte OM, Bergerson JRE, Burbelo PD, Durkee-Shock JR, Dobbs K, Bosticardo M, et al. Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity. J Allergy Clin Immunol. 2021;148(5):1192\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1296_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jaci.2021.05.029","volume":"148","author":"D Hagin","year":"2021","unstructured":"Hagin D, Freund T, Navon M, Halperin T, Adir D, Marom R, et al. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity. J Allergy Clin Immunol. 2021;148(3):739\u201349.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1296_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.anai.2021.05.015","volume":"127","author":"J Squire","year":"2021","unstructured":"Squire J, Joshi A. Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency. Ann Allergy Asthma Immunol. 2021;127(3):383\u20134.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"1296_CR12","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jaip.2018.12.004","volume":"7","author":"CA Filion","year":"2019","unstructured":"Filion CA, Taylor-Black S, Maglione PJ, Radigan L, Cunningham-Rundles C. Differentiation of common variable immunodeficiency from IgG deficiency. J Allergy Clin Immunol Pract. 2019;7(4):1277\u201384.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"1296_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s10875-020-00773-y","volume":"40","author":"JJ Shin","year":"2020","unstructured":"Shin JJ, Liauw D, Siddiqui S, Lee J, Chung EJ, Steele R, et al. Immunological and clinical phenotyping in primary antibody deficiencies: a growing disease spectrum. J Clin Immunol. 2020;40(4):592\u2013601.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1296_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10875-021-00968-x","volume":"41","author":"JJ Shin","year":"2021","unstructured":"Shin JJ, Catanzaro J, Yonkof JR, Delmonte O, Sacco K, Shin MS, et al. Infectious complications predict premature CD8(+) T-cell senescence in CD40 ligand-deficient patients. J Clin Immunol. 2021;41(4):795\u2013806.","journal-title":"J Clin Immunol"},{"issue":"66","key":"1296_CR15","doi-asserted-by":"publisher","first-page":"eabl5344","DOI":"10.1126\/sciimmunol.abl5344","volume":"6","author":"G Guerrera","year":"2021","unstructured":"Guerrera G, Picozza M, D\u2019Orso S, Placido R, Pirronello M, Verdiani A, et al. BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype. Sci Immunol. 2021;6(66):eabl5344.","journal-title":"Sci Immunol"},{"issue":"10","key":"1296_CR16","doi-asserted-by":"publisher","first-page":"e0186998","DOI":"10.1371\/journal.pone.0186998","volume":"12","author":"S Reiss","year":"2017","unstructured":"Reiss S, Baxter AE, Cirelli KM, Dan JM, Morou A, Daigneault A, et al. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells. PLoS One. 2017;12(10):e0186998.","journal-title":"PLoS One"},{"issue":"4","key":"1296_CR17","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher C, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;183(4):996-1012.e19.","journal-title":"Cell"},{"issue":"3","key":"1296_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/gerona\/glr237","volume":"67","author":"N Lee","year":"2012","unstructured":"Lee N, Shin MS, Kang I. T-cell biology in aging, with a focus on lung disease. J Gerontol A Biol Sci Med Sci. 2012;67(3):254\u201363.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"1296_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38\u201359.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"1296_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/cei.12178","volume":"174","author":"R Ameratunga","year":"2013","unstructured":"Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol. 2013;174(2):203\u201311.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"1296_CR21","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1016\/j.jaip.2021.06.019","volume":"9","author":"R Ameratunga","year":"2021","unstructured":"Ameratunga R, Longhurst H, Steele R, Lehnert K, Leung E, Brooks AES, et al. Common variable immunodeficiency disorders, T-cell responses to SARS-CoV-2 vaccines, and the risk of chronic COVID-19. J Allergy Clin Immunol Pract. 2021;9(10):3575\u201383.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1296_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.","journal-title":"Front Immunol"},{"issue":"16","key":"1296_CR23","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113(16):3716\u201325.","journal-title":"Blood"},{"issue":"1","key":"1296_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","volume":"22","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty S, Gonzalez J, Edwards K, Mallajosyula V, Buzzanco AS, Sherwood R, et al. Proinflammatory IgG Fc structures in patients with severe COVID-19. Nat Immunol. 2021;22(1):67\u201373.","journal-title":"Nat Immunol"},{"key":"1296_CR25","doi-asserted-by":"crossref","unstructured":"Klingler J, Weiss S, Itri V, Liu X, Oguntuyo KY, Stevens C et al. Role of IgM and IgA antibodies in the neutralization of SARS-CoV-2. medRxiv. 2020;\u00a023(6):957\u201370.","DOI":"10.1101\/2020.08.18.20177303"},{"issue":"2","key":"1296_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","volume":"27","author":"KJ Ewer","year":"2021","unstructured":"Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R, et al. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial. Nat Med. 2021;27(2):270\u20138.","journal-title":"Nat Med"},{"key":"1296_CR27","doi-asserted-by":"publisher","first-page":"632814","DOI":"10.3389\/fimmu.2021.632814","volume":"12","author":"H Luo","year":"2021","unstructured":"Luo H, Jia T, Chen J, Zeng S, Qiu Z, Wu S, et al. The characterization of disease severity associated IgG subclasses response in COVID-19 patients. Front Immunol. 2021;12:632814.","journal-title":"Front Immunol"},{"key":"1296_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.immunol.23.021704.115839","volume":"23","author":"TH Watts","year":"2005","unstructured":"Watts TH. TNF\/TNFR family members in costimulation of T cell responses. Annu Rev Immunol. 2005;23:23\u201368.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"1296_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-020-00243-2","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, et al. COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduct Target Ther. 2020;5(1):128.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"1296_CR30","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.4049\/jimmunol.178.6.3932","volume":"178","author":"A Giovannetti","year":"2007","unstructured":"Giovannetti A, Pierdominici M, Mazzetta F, Marziali M, Renzi C, Mileo AM, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol. 2007;178(6):3932\u201343.","journal-title":"J Immunol"},{"issue":"8","key":"1296_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/jclinpath-2015-203351","volume":"69","author":"GK Wong","year":"2016","unstructured":"Wong GK, Huissoon AP. T-cell abnormalities in common variable immunodeficiency: the hidden defect. J Clin Pathol. 2016;69(8):672\u20136.","journal-title":"J Clin Pathol"},{"issue":"1","key":"1296_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2020.11.029","volume":"184","author":"LB Rodda","year":"2021","unstructured":"Rodda LB, Netland J, Shehata L, Pruner KB, Morawski PA, Thouvenel CD, et al. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. Cell. 2021;184(1):169-83.e17.","journal-title":"Cell"},{"issue":"7","key":"1296_CR33","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1182\/blood-2005-09-3560","volume":"107","author":"HR Kim","year":"2006","unstructured":"Kim HR, Hong MS, Dan JM, Kang I. Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. Blood. 2006;107(7):2855\u201362.","journal-title":"Blood"},{"issue":"9","key":"1296_CR34","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/rheumatology\/kes100","volume":"51","author":"JS Kim","year":"2012","unstructured":"Kim JS, Cho BA, Sim JH, Shah K, Woo CM, Lee EB, et al. IL-7Ralphalow memory CD8+ T cells are significantly elevated in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2012;51(9):1587\u201394.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"1296_CR35","doi-asserted-by":"publisher","first-page":"e12960","DOI":"10.1111\/acel.12960","volume":"18","author":"HJ Park","year":"2019","unstructured":"Park HJ, Shin MS, Kim M, Bilsborrow JB, Mohanty S, Montgomery RR, et al. Transcriptomic analysis of human IL-7 receptor alpha (low) and (high) effector memory CD8(+) T cells reveals an age-associated signature linked to influenza vaccine response in older adults. Aging Cell. 2019;18(4):e12960.","journal-title":"Aging Cell"},{"issue":"4","key":"1296_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cell.2011.01.011","volume":"144","author":"M Pellegrini","year":"2011","unstructured":"Pellegrini M, Calzascia T, Toe JG, Preston SP, Lin AE, Elford AR, et al. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell. 2011;144(4):601\u201313.","journal-title":"Cell"},{"issue":"24","key":"1296_CR37","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","volume":"115","author":"I Isnardi","year":"2010","unstructured":"Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, Srdanovic I, et al. Complement receptor 2\/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010;115(24):5026\u201336.","journal-title":"Blood"},{"issue":"1","key":"1296_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77\u201385.","journal-title":"Blood"},{"issue":"6","key":"1296_CR39","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/j.jaci.2018.02.052","volume":"142","author":"A Gardulf","year":"2018","unstructured":"Gardulf A, Abolhassani H, Gustafson R, Eriksson LE, Hammarstrom L. Predictive markers for humoral influenza vaccine response in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2018;142(6):1922-31.e2.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01296-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01296-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01296-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T17:48:58Z","timestamp":1665078538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01296-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1296"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01296-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"assertion":[{"value":"4 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Yale University Institutional Review Board (IRB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The Informed consent for the study was obtained from all participating study subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All study subjects were de-identified. No data were associated with personal identifiable information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"MKR is an employee of Quest Diagnostics. IK and RB received research funding from Quest Diagnostics.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}